• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • TB
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • TB
    • View Item
    Apr 22, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Achar J - 2017 - Off-Label Use ...
    Size:
    346.3Kb
    Format:
    PDF
    Download
    Authors
    Achar, J
    Hewison, C
    Cavalheiro, AP
    Skrahina, A
    Cajazeiro, J
    Nargiza, P
    Herboczek, K
    Rajabov, A
    Hughes, J
    Ferlazzo, G
    Seddon, JA
    du Cros, P
    Show allShow less
    Issue Date
    2017-10
    Submitted date
    2017-10-18
    
    Metadata
    Show full item record
    Journal
    Emerging Infectious Diseases
    Abstract
    We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited.
    Publisher
    Centers for Disease Control and Prevention
    URI
    http://hdl.handle.net/10144/619030
    DOI
    10.3201/eid2310.170303
    PubMed ID
    28758889
    Language
    en
    ISSN
    1080-6059
    ae974a485f413a2113503eed53cd6c53
    10.3201/eid2310.170303
    Scopus Count
    Collections
    TB

    entitlement

    Related articles

    • Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    • Authors: Centers for Disease Control and Prevention.
    • Issue date: 2013 Oct 25
    • Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    • Authors: Worley MV, Estrada SJ
    • Issue date: 2014 Nov
    • Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
    • Authors: Mbuagbaw L, Guglielmetti L, Hewison C, Bakare N, Bastard M, Caumes E, Fréchet-Jachym M, Robert J, Veziris N, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Schünemann HJ, Lienhardt C
    • Issue date: 2019 May
    • The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report.
    • Authors: Park S, Lee KM, Kim I, Mok J
    • Issue date: 2018 Nov
    • Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
    • Authors: Kunkel A, Cobelens FG, Cohen T
    • Issue date: 2016 Oct
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.